CD163+ TAMs drive the EMT process in primary CRC tumor cells through the IL-6/STAT3/miR-506-3p/Foxc1 axis, prompting CRC cell invasion to generate mesenchymal CTCs. This evidence concerns the gene IL6 and neoplasm.